Deploy medical AI technology in all 196 countries and regions by fiscal 2030
First written in FY2022. 5 of 6 entries say "Advanced", first in FY2023. Latest entry: FY2026.
No other company in this theme has enough history to compare yet.
- FY2026AdvancedAnnual report
「The company has so far expanded into 5 countries. Through NURA, it will continue to enhance the competitiveness of its Medical Systems business by reflecting operational issues and latent needs identified in the field into the advancement of AI technologies and the development of new products, in addition to providing value through its health screening business.」
For NURA, the company has disclosed deployment in 5 countries and made its operating model more tangible by feeding issues and latent needs identified at health screening sites into AI enhancement and new product development. - 2026-05-29AdvancedGeneral Meetings of Shareholders
「By fiscal 2030, we aim to introduce and deploy products and services using medical AI technologies in 196 countries. As of the end of fiscal 2025, they had been deployed in 117 countries.」
The number of countries introducing medical AI products and services increased from 115 to 117, while the target of 196 countries by fiscal 2030 remains in place. - FY2025AdvancedAnnual report
「In the area of health, the company aims to expand by fiscal 2030 the number of countries where products and services using medical AI technologies are deployed from 115 in fiscal 2024 to all 196 countries worldwide.」
The number of countries where medical AI products and services are deployed increased from 100 to 115, and the target of deployment in 196 countries by fiscal 2030 remains in place. - FY2024AdvancedAnnual report
「In the area of health, the company aims to expand by fiscal 2030 the number of countries where products and services using medical AI technologies are deployed from 100 in fiscal 2023 to all 196 countries worldwide.」
The number of countries where medical AI products and services are deployed increased from approximately 93 in fiscal 2022 to 100 in fiscal 2023, and the target of deployment in 196 countries by fiscal 2030 remains in place. - FY2023AdvancedAnnual report
「In the area of health, the company aims to expand by fiscal 2030 the number of countries and regions where products and services using medical AI technologies are deployed from approximately 93 in fiscal 2022 to all 196 countries and regions worldwide.」
The number of countries where medical AI products and services are deployed increased from approximately 70 to approximately 93 in fiscal 2022, and the target of deployment across all 196 countries and regions worldwide by fiscal 2030 was reaffirmed. - FY2022First statedAnnual report
「In the area of health, the company aims to expand by fiscal 2030 the number of countries and regions where products and services using medical AI technologies are deployed from approximately 70 in fiscal 2021 to all 196 countries and regions worldwide.」
The company has stated for the first time a target of expanding the number of countries where medical AI products and services are deployed from approximately 70 in fiscal 2021 to all 196 countries and regions worldwide by fiscal 2030.